TY  - JOUR
AU  - Abdulkarim, Louay S
AU  - Motley, Richard J
PY  - 2021
DA  - 2021/12/15
TI  - First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?
JO  - JMIR Cancer
SP  - e29912
VL  - 7
IS  - 4
KW  - advanced cutaneous melanoma
KW  - first-line treatments
KW  - immunotherapy
KW  - targeted therapy
KW  - combinational therapy
KW  - dermatologic adverse events
KW  - cutaneous side effects
SN  - 2369-1999
UR  - https://cancer.jmir.org/2021/4/e29912
UR  - https://doi.org/10.2196/29912
UR  - http://www.ncbi.nlm.nih.gov/pubmed/34914610
DO  - 10.2196/29912
ID  - info:doi/10.2196/29912
ER  -